A. G. Lynn

发表

Neuropharmacological studies in rodents on the action of RX 781094, a new selective α2-adrenoceptor antagonist

P. Dettmar, I. Tulloch, A. G. Lynn, 1983, Neuropharmacology.

Neuropharmacological evaluation of RX 77368—a stabilised analogue of thyrotropin-releasing hormone (TRH)

G. Metcalf, P. Dettmar, I. Tulloch, 1982, Regulatory Peptides.

Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability

G. Metcalf, D. Brewster, P. Dettmar, 1981, Regulatory Peptides.

Modification of the proline residue of TRH enhances biological activity and inhibits degradation.

G. Metcalf, B. Morgan, P. Dettmar, 1980, European journal of pharmacology.

The ability of RX 77368 — A stabilised analogue of TRH — To provoke the secretion of prolactin and TSH in vivo

G. Metcalf, P. Dettmar, A. G. Lynn, 1982, Neuropeptides.

Opiate analgesics: the effect of agonist‐antagonist character on prolactin secretion

G. Metcalf, P. Dettmar, B. Brown, 1978, The Journal of pharmacy and pharmacology.

Development of a radioimmunoassay for idazoxan hydrochloride.

R. Coxon, J. Landon, G. Gallacher, 1990, Journal of pharmaceutical and biomedical analysis.

Anorectic actions of the opiate antagonist naloxone.

D. Sanger, P. Dettmar, A. G. Lynn, 1981, Neuropharmacology.

Biological evaluation of a TRH analogue with a modified proline residue

G. Metcalf, B. Morgan, P. Dettmar, 1980, Neuropharmacology.

Brain TRH receptors are the same as pituitary TRH receptors

G. Metcalf, B. Morgan, P. Dettmar, 1983, The Journal of pharmacy and pharmacology.